A carregar...
A novel prognostic six‐CpG signature in glioblastomas
AIMS: We aimed to identify a clinically useful biomarker using DNA methylation‐based information to optimize individual treatment of patients with glioblastoma (GBM). METHODS: A six‐CpG panel was identified by incorporating genome‐wide DNA methylation data and clinical information of three distinct...
Na minha lista:
| Publicado no: | CNS Neurosci Ther |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6489960/ https://ncbi.nlm.nih.gov/pubmed/29350455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12786 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|